Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 243 publications
Reply to Antonio Cigliola, Andrea Necchi, and Umberto Capitanio's Letter to the Editor Re: Metastasis-directed Therapy with or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.
Journal: European urology
Published: June 18, 2026
Pan-cancer spatial atlas of tertiary lymphoid structures.
Journal: Science (New York, N.Y.)
Published: May 28, 2026
CXCL13-CXCR5 Signaling in CD8⁺ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
CXCL13-CXCR5 Signaling in CD8+ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2026
CXCL13-CXCR5 signaling in CD8+ T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 03, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.
Journal: JCO clinical cancer informatics
Published: May 01, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.
Journal: JCO precision oncology
Published: March 30, 2026
Kidney Cancer Trends, Risk Factors, and Interventions in American Indian and Alaska Native Populations: The Kidney Cancer Association Scientific Statement.
Journal: Cancers
Published: March 19, 2026
Beyond binary classification of non-proportional hazards: Methodological considerations for interpreting pivotal HCC trials.
Journal: Journal of hepatology
Published: March 17, 2026
Identifying new targets for the treatment of renal medullary carcinoma: from biological hallmarks to precision therapies.
Journal: Future oncology (London, England)
Published: March 04, 2026
Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 16, 2026
Last Updated: 09/26/2026